GRM1 and melanoma: To finally determine whether AP2ε has an impact on melanoma development and progression in vivo, we crossbred AP2ε-deficient mice with a transgenic melanoma model (Tg(GRM1)), a murine model for spontaneous melanoma development [20, 36].